Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum AIkido Pharma SPEX

AIkido Pharma Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).

NDAQ:SPEX - Post Discussion

AIkido Pharma > Definitive agreement announced yesterday, @ $2.75,
View:
Post by Subchimes1 on Mar 10, 2020 1:55pm

Definitive agreement announced yesterday, @ $2.75,

Definitive agreement announced On March 9th, for 5.75 million, @$2.75, why are we trading below that today? Press release,  should close at or around March 11th, looks like its trading very cheap right now.
Comment by thedave2006 on Mar 11, 2020 11:34am
pump a doodle do on twitter feeds?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities